Axon Enterprise (AXON)
(Delayed Data from NSDQ)
$404.51 USD
+5.29 (1.33%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $404.53 +0.02 (0.00%) 6:50 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$404.51 USD
+5.29 (1.33%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $404.53 +0.02 (0.00%) 6:50 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Zacks News
Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Axon (AXON) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Axon Enterprise (AXON) Displays Bright Prospects Amid Risks
by Zacks Equity Research
Axon Enterprise (AXON) gains from solid momentum in its business and robust product offerings. However, high operating costs and expenses remain concerns.
Axon Enterprise, Inc (AXON) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Axon (AXON) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Axon (AXON). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Axon Enterprise (AXON) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Axon Enterprise's (AXON) Q1 revenues increase 34.3% year over year, driven by the impressive performance of its Software & Sensors and TASER segments.
Here's What Key Metrics Tell Us About Axon (AXON) Q1 Earnings
by Zacks Equity Research
Although the revenue and EPS for Axon (AXON) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Any World Markets Not Fed-Linked? Global Week Ahead
by John Blank
Insulating a portfolio from Wall Street's swings is tough. The long-term correlation rate between Europe's Stoxx 600 and the S&P is almost 90%.
Emerson Electric (EMR) to Post Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Emerson Electric (EMR) Q2 results are likely to benefit from strong demand, solid backlog and contributions from acquisitions. However, high operating expenses might have affected its margins.
Take the Zacks Approach to Beat the Markets: Navios Maritime, Coinbase Global, Virtu Financial in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Top 5 Stocks Poised to Beat on Earnings This Week
by Nalak Das
We have narrowed our search to five large-cap stocks that are poised to beat on earnings results this week. These are: AXON, BLD, ANET, EMR, HOOD.
Is a Surprise Coming for Axon Enterprise (AXON) This Earnings Season?
by Zacks Equity Research
Axon Enterprise (AXON) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What Analyst Projections for Key Metrics Reveal About Axon (AXON) Q1 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Axon (AXON) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
What's in the Offing for Stanley Black (SWK) in Q1 Earnings?
by Zacks Equity Research
Stanley Black's (SWK) first-quarter 2024 results are likely to benefit from strength in the Engineered Fastening business.
Parker-Hannifin (PH) to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Parker-Hannifin's (PH) fiscal third-quarter performance is expected to have gained from solid demand for its products across the aerospace, oil & gas and agriculture end markets.
Ingersoll Rand (IR) to Post Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Ingersoll Rand's (IR) Q1 results are likely to benefit from strong demand, pricing actions and contributions from acquisitions. However, high operating expenses might have affected its margins.
Johnson Controls (JCI) Tops Q2 Earnings Estimates
by Zacks Equity Research
Johnson Controls (JCI) delivered earnings and revenue surprises of 4% and 0.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AXON Gears Up to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Axon's (AXON) first-quarter 2024 earnings are expected to have gained from strong demand for TASER devices and higher cartridge revenues.
Is a Beat in Store for Atmus Filtration (ATMU) in Q1 Earnings?
by Zacks Equity Research
Atmus Filtration's (ATMU) first-quarter performance is expected to benefit from solid momentum in first-fit markets and robust demand for the Fleetguard brand.
Xylem (XYL) to Post Q1 Earnings: What's in the Offing? (revised)
by Zacks Equity Research
Xylem's (XYL) first-quarter 2024 results are likely to gain from strength across its utilities and industrial end markets despite weakness in the residential building solutions end market.
Proto Labs (PRLB) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Proto Labs' (PRLB) first-quarter 2024 results are likely to reflect the impacts of lower order levels seen in the earlier part of the quarter.
Cadre Holdings, Inc. (CDRE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cadre Holdings, Inc. (CDRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) to Post Q1 Earnings: What's in the Offing? (revised)
by Zacks Equity Research
Xylem's (XYL) first-quarter 2024 results are likely to gain from strength across its utilities and industrial end markets despite weakness in the residential building solutions end market.
Axon Enterprise (AXON) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the most recent trading session, Axon Enterprise (AXON) closed at $313.30, indicating a +1.64% shift from the previous trading day.
What to Note Ahead of Johnson Controls' (JCI) Q2 Earnings?
by Zacks Equity Research
Johnson Controls' (JCI) fiscal second-quarter results are likely to benefit from continued improvement in the HVAC & Controls business.
Powell (POWL) Gears Up to Post Q2 Earnings: Is a Beat Likely?
by Zacks Equity Research
Powell's (POWL) second-quarter fiscal 2024 results are expected to benefit from solid momentum across petrochemical, oil and gas sectors, partly offset by cost inflation.